Touyun Biotech Group (HKSE:01332) Cyclically Adjusted PS Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01332 Touyun Biotech Group Ltd HKSE:01332
27 GF Score
Price HK$0.16
GF Value HK$0.09
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Touyun Biotech Group Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Touyun Biotech Group  (HKSE:01332) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Touyun Biotech Group Cyclically Adjusted PS Ratio Related Terms


Touyun Biotech Group Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Touyun Biotech Group's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Touyun Biotech Group Cyclically Adjusted PS Ratio Chart

Touyun Biotech Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.16 2.00 1.37 1.54 2.90

Touyun Biotech Group Semi-Annual Data
Jun16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.07 1.54 0.67 2.90 1.46

HKSE:01332 vs SW, AMCR, PKG: Cyclically Adjusted PS Ratio Comparison

For the Packaging & Containers subindustry, Touyun Biotech Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Touyun Biotech Group Cyclically Adjusted PS Ratio vs Packaging & Containers Industry

For the Packaging & Containers industry and Consumer Cyclical sector, Touyun Biotech Group's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Touyun Biotech Group's Cyclically Adjusted PS Ratio falls into.


HKSE:01332
27GF Score
Touyun Biotech Group Ltd HKSE:01332
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Touyun Biotech Group Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Touyun Biotech Group's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec25 is calculated as:

For example, Touyun Biotech Group's adjusted Revenue per Share data for the fiscal year that ended in Dec25 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec25 (Change)*Current CPI (Dec25)
=0.024/120.7036*120.7036
=0.024

Current CPI (Dec25) = 120.7036.

Touyun Biotech Group Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201612 -0.023 103.225 -0.027
201712 0.130 104.984 0.149
201812 0.142 107.622 0.159
201912 0.140 110.700 0.153
202012 0.077 109.711 0.085
202112 0.101 112.349 0.109
202212 0.113 114.548 0.119
202312 0.071 117.296 0.073
202412 0.035 118.945 0.036
202512 0.024 120.704 0.024

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Touyun Biotech Group (HKSE:01332) Overvalued in 2026?

Based on GuruFocus' analysis, Touyun Biotech Group stock appears to be overvalued. The current stock price of HK$0.16 is trading 76.7% above its estimated GF Value™ of HK$0.09. GuruFocus considers Touyun Biotech Group to be Significantly Overvalued.

Key valuation signals for HKSE:01332:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: HK$0.09 vs. price of HK$0.16 (76.7% above fair value)
  • GF Score™: 27/100 with 6 warning signs

No single metric tells the full story. See the HKSE:01332 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Touyun Biotech Group Business Description

Address 6 Tonnochy Road, 12th Floor, Kwan Chart Tower, Wanchai, Hong Kong, HKG
Touyun Biotech Group Ltd is principally engaged in the (i) the manufacture and sale of packaging products; (ii) investments and trading in securities and money lending, and (iii) production and sale of Chlamydomonas reinhardtii, micro-algae and related products. The company generates majority of its revenue from packaging products segment.
27GF Score

Get the complete analysis for HKSE:01332

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.16
Price
HK$0.09
GF Value